Cargando…
Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark
BACKGROUND: Besides being a causative agent for genital warts and cervical cancer, human papillomavirus (HPV) contributes to 40-85% of cases of anal, penile, vaginal and vulvar cancer and precancerous lesions. HPV types 16 & 18 in particular contribute to 74-93% of these cases. Overall the numbe...
Autores principales: | Olsen, Jens, Jørgensen, Tine Rikke, Kofoed, Kristian, Larsen, Helle Kiellberg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546065/ https://www.ncbi.nlm.nih.gov/pubmed/23244352 http://dx.doi.org/10.1186/1471-2458-12-1082 |
Ejemplares similares
-
Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females
por: Olsen, Jens, et al.
Publicado: (2015) -
Challenges and controversies patients and (health care) professionals experience in managing vaginal, vulvar, penile or anal cancer: The SILENCE study
por: van Dongen, Jessy, et al.
Publicado: (2022) -
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022) -
Familial Clustering, Second Primary Cancers and Causes of Death in Penile, Vulvar and Vaginal Cancers
por: Zhang, Luyao, et al.
Publicado: (2019) -
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
por: Terkelsen, David, et al.
Publicado: (2017)